Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
NCT06950034
- Conditions
- Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), +24 more
- Locations
-
- Stanford University Stanford, California, United States
- Moffitt Tampa, Florida, United States
- DFCI Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
Not Yet Recruiting
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327
- Conditions
- AML (Acute Myelogenous Leukemia), Anemia, Anemia, Refractory, +16 more
- Locations
-
- CareDx, Inc. Brisbane, California, United States
NCT04139434
- Conditions
- AML/MDS, CMML, Disease Attributes, +20 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
- MD Anderson Cancer Center Huston, Texas, United States
NCT04473911
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia, +37 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT02193958
- Conditions
- AML, Bone Marrow Diseases, CMML, +15 more
- Locations
-
- Cleveland Clinic at Taussig Cancer Center Cleveland, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
Completed
IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
NCT04372433
- Conditions
- AML With Monocytic Differentiation, CMML
- Locations
-
- University California, Davis (117) Davis, California, United States
- City of Hope (106) Duarte, California, United States
- University of California, Irvine (107) Irvine, California, United States
- UCLA, Medical Center Division of Hematology/Oncology (119) Los Angeles, California, United States
Completed
SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
NCT01261312
- Conditions
- AML, CMML, MDS
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- University of Southern California Los Angeles, California, United States
- Yale University New Haven, Connecticut, United States
- Florida Cancer Specialists - South Fort Myers, Florida, United States
NCT02581007
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +41 more
- Locations
-
- Northside Hospital Atlanta, Georgia, United States
NCT03526666
- Conditions
- AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
- Locations
-
- Cancer and Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
- Metro Health - University of Michigan Health Wyoming, Michigan, United States
Active, Not Recruiting
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
NCT04730258
- Conditions
- AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +19 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Norton Cancer Institute - Saint Matthews Louisville, Kentucky, United States
- New York Presbyterian Weill Cornell Medical Center New York, United States